Cornelius E. J. Sloots

Suggest Changes
Learn More
PURPOSE Infliximab has been reported to improve fistulizing Crohn's disease. Moreover, prompt healing of mucosal ulcers has been described. Whether fistulas disappear or remainders of fistulas(More)